Subcutaneous adipose tissue expression of tumour necrosis factor-α is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects

European Journal of Clinical Investigation

Volumn 30, Issue 4, 2000, Pages 302-310

  Koistinen, Heikki A ^h   Bastard, J P ^a   Dusserre, E ^b,c,f   Ebeling, P ^j   Zegari, N ^d   Andreelli, F ^c,f   Jardel, C ^a   Donner, M ^d   Meyer, L ^e,g   Moulin, P ^b   Hainque, B ^a   Riou, J P ^c,f   Laville, M ^c,f   Koivisto, V A ⁱ   Vidal, H ^c,f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Hopital de l'Antiquaille   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

^e Service de Diabetologie   (France)

^f INSERM   (France)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ Lilly Research Laboratories   (Germany)

^j Helsinki Univ Central Hospital ^*

more..

Author keywords

Cytokine; Factor ; Hyperinsulinaemic clamp; Insulin resistance; Obesity; Tumour necrosis

Indexed keywords

INSULIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; BODY MASS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; INULIN; MALE; MIDDLE AGED; OBESITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0006597145     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00625.x     Document Type: Article

References (35)

1. 1 Beutler B, Cerami A. The biology of cachectin/TNF-α: a primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
2. 2 Van der Poll T, Romijn JA, Enden E et al. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1991;261:E457-E465.
3. 3 McCall JL, Tuckey JA, Parry BR. Serum tumor necrosis factor alpha and insulin resistance in gastrointestinal cancer. Br J Surg 1992;79:1361-3.
4. 4 Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor α inhibits signaling from the insulin receptor. Proc Natl Acad Sci 1994;91:4854-8.
5. 5 Liu LS, Spelleken M, Röhrig K, Hauner H, Eckel J. Tumor necrosis factor-α acutely inhibits insulin signaling in human adipocytes. Implication of the p80 tumor necrosis factor receptor. Diabetes 1998;47:515-22.
6. 6 Hotamisligil GS, Spiegelman BM. Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-8.
7. 7 Kanery H, Feinstein R, Papa MZ, Hemi R, Karasik R, Karasik A. Tumor necrosis factor-α induced phosphorylation of insulin receptor substrate-1 (IRS-1). J Biol Chem 1995;270:23780-4.
8. 8 Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity -induced insulin resistance. Science 1996;271:665-8.
9. 9 Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
10. 10 Flier JS. The adipocyte: storage depot or node on the energy information superhighway? Cell 1995;80:15-8.
11. 11 Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995;95:2111-9.
12. 12 Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995;95:2409-15.
13. 13 Frittitta L, Youngren JF, Sbraccia P et al. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-α gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 1997;40:282-9.
14. 14 Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNFα antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996;45:881-5.
15. 15 Kellerer M, Rett K, Renn W, Groop L, Häring HU. Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res 1996;28:737-43.
16. 16 Pfeiffer A, Janott J, Möhlig M et al. Circulating tumor necrosis factor α is elevated in male but not in female patients with type II diabetes mellitus. Horm Metab Res 1997;29:111-4.
17. 17 Katsuki A, Sumida Y, Murashima S et al. Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998;83:859-62.
18. 18 Winkler G, Salamon F, Salamon D, Speer G, Simon K, Cseh K. Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (noninsulin-dependent) diabetes and in obesity (Letter). Diabetologia 1998;41:860-1.
19. 19 Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1998;18:1199-202.
20. 20 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
21. 21 Ebeling P, Tuominen JA, Bourey R, Koranyi L, Koivisto VA. Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivity. Diabetes 1995;44:471-7.
22. 22 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
23. 23 Vidal H, Auboeuf D, De Vos P et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 1996;98:251-5.
24. 24 Auboeuf D, Vidal H. The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. Anal Biochem 1997;245:141-8.
25. 25 Auboeuf D, Rieusset J, Fajas L et al. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: No alteration in adipose tissue of obese and NIDDM patients. Diabetes 1997;46:1319-27.
26. 26 Millet L, Vidal H, Andreelli F et al. Increased Uncoupling Protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 1997;100:2665-70.
27. 27 Pennica D, Nedwin GE, Hayflick JS et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984;312:724-9.
28. 28 De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239-48.
29. 29 Wilkinson L. SYSTAT: The system for statistics. Evanston, IL, SYSTAT Inc 1990.
30. 30 Koistinen H, Ebeling P, Tuominen JA, Valuer P, Laville M, Koivisto VA et al. Subcutaneous adipose tissue PAI-1 gene expression has a diurnal variation and it correlates with obesity and insulin resistance. Diabetes 1999;48 (Suppl. 1):A313 ((Abstract) 1368).
31. 31 DeFronzo RA. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37: 667-87.
32. 32 Montague CT, Prins JB, Sanders L et al. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998;47:1384-91.
33. 33 Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
34. 34 Saad MF, Damani S, Gingerich RL et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Melab 1997;82:579-84.
35. 35 Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997;82: 4196-200.